Prevalence of aminoglycoside and tetracycline resistance genes and their association with virulence factors in clinical isolates of Acinetobacter baumannii

Paper Details

Research Paper 01/09/2019
Views (209) Download (11)

Prevalence of aminoglycoside and tetracycline resistance genes and their association with virulence factors in clinical isolates of Acinetobacter baumannii

Shahzeera Begum, Muneela Shaheen, Amir Afzal Khan, Rabaab Zahra
Int. J. Biosci.15( 3), 392-399, September 2019.
Certificate: IJB 2019 [Generate Certificate]


High prevalence of antibiotic resistance in Acinetobacter baumannii(A. baumannii) is a serious threat to modern health care system due to its inherent and acquired resistance mechanism.It is difficult to treat and becoming resistant to various classes of antibiotics. The aim of the study was to investigate aminoglycoside and tetracyclineantibiotic resistancegenes in A. baumannii and their correlation with virulence factors. A total of 240 clinical A. baumannii isolates collected from Pakistan Institute of Medical Sciences (PIMS) were preceded for the present study. Initially isolates were identified by using standard microbiologicaltechniques. Antibiotic susceptibility assay was performed using Kirby Bauer disk diffusion method. Polymerase chain reaction (PCR) was done for screening of antibiotic resistance genesand virulence factors. PCR results showed that among aminoglycoside resistance genes20%, 8%, 1% and 0.42% of isolates were found positive for aaC1, aadA1, aadB and aphA6genes respectively. In case of tetracycline resistance genes, 13% isolates were positive for tetB and 1% for tetA. Among virulence factors, only one isolate harboredcsgA gene and none of the isolates were positive foriutA, cnf1 and cvaC. It was concluded that due to residing on same genetic elements antibiotic resistance genes suppress the effect of virulence factors.


Al-Anazi KA, Al-Jasser AM. 2014. Infections caused by Acinetobacter baumannii in recipients of hematopoietic stem cell transplantation. Frontiers in Oncology (4), 186.

Aliakbarzade K, Farajnia S, Nik AK, Zarei F, Tanomand A. 2014. Prevalence of aminoglycoside resistance genes in Acinetobacter baumannii isolates. Jundishapur Journal of Microbiology 7(10).

Asadollahi P, Akbari M, Soroush S, Taherikalani M, Asadollahi K, Sayehmiri K, Emaneini M. 2012. Antimicrobial resistance patterns and their encoding genes among Acinetobacter baumannii strains isolated from burned patients. Burns 38(8), 1198-1203.

Bauer AW, Kirby WM, Sherris JC, Turck M. 1966. Antibiotic susceptibility testing by a standardized single disk method. American journal of clinical pathology 1; 45(4_ts), 493-496.

Begum S, Hasan F, Hussain S, Shah AA. 2013. Prevalence of multi drug resistant Acinetobacter baumannii in the clinical samples from Tertiary Care Hospital in Islamabad, Pakistan. Pakistan Journal of Medical Sciences 29(5), 1253.

Bush K, Jacoby GA. 2010. Updated functional classification of β-lactamases. Antimicrobial Agents and Chemotherapy 54(3), 969-976.

Chang Y, Luan G, Xu Y, Wang Y, Shen M, Zhang C, Zheng W, Huang J, Yang J, Jia X, Ling B. 2015. Characterization of carbapenem-resistant Acinetobacter baumannii isolates in a Chinese teaching hospital. Frontiers in   Microbiology 6, 910.

Darvishi M. 2016. Virulence factors profile and antimicrobial resistance of Acinetobacter baumannii strains isolated from various infections recovered from immunosuppressive patients. Biomedical and Pharmacology Journal 9(3), 1057-1062.

Daryanavard R, Safaei HR. 2015.  Virulence genes and antimicrobial resistance properties of Acinetobacter baumannii isolated from pediatrics suffered from UTIs. International Journal of Advanced Research in Biological Sciences 2(11), 272-9.

Doi Y, Murray GL, Peleg AY. Acinetobacter baumannii. 2015. Evolution of antimicrobial resistance-treatment options. Seminars in Respiratory and Critical Care Medicine 36, 85-98.

Eijkelkamp BA, Stroeher UH, Hassan KA, Paulsen IT, Brown MH. 2014. Comparative analysis of surface-exposed virulence factors of Acinetobacter baumannii BMC Genomics (25)15, 1020.

Eraç B1, Yýlmaz FF, HoogörLimoncu M, Oztürk I, Aydemir S. 2014. Investigation of the virulence factors of multidrug-resistant Acinetobacter baumannii isolates. Mikrobiyoloji Bulteni 48(1), 70- 81.

Farsiani H, Mosavat A, Soleimanpour S, Nasab MN, Salimizand H, Jamehdar SA,  Baghani AA. 2015. Limited genetic diversity and extensive antimicrobial resistance in clinical isolates of Acinetobacter baumannii in north-east Iran. Journal of Medical Microbiology 64(7), 767-773.

Hasan B, Perveen K, Olsen B and Zahra R. 2014. Emergence of carbapenem-resistant Acinetobacter baumannii in hospitals in Pakistan. Journal of Medical Microbiology 63(1), 50-55.

Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, Thomson JM. 2006. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Center. Antimicrobial Agents and Chemotherapy 50(12), 4114-4123.

Imperi F, Antunes LC, Blom J, Villa L, Iacono M, Visca P, Carattoli A. 2011. The genomics of Acinetobacter baumannii: insights into genome plasticity, antimicrobial resistance and pathogenicity. International Union of Biochemistry and Molecular Biology (63), 1068-1074.

Indhar F, Durrani MA, Bux A and Sohail M. 2017. Carbapenemases among Acinetobacter species isolated from NICU of a tertairy care hospital in Karachi. Journal of Pakistan Medical Association.  67(1547).

Lin MF, Lan CY. 2014. Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside. World Journal of Clinical Cases (2), 787-814.

Maleki MH, Sekawi Z, Soroush S, Azizi-Jalilian, F, Asadollahi K, Mohammadi S, Taherikalani M. 2014. Phenotypic and genotypic characteristics of tetracycline resistant Acinetobacter baumannii isolates from nosocomial infections at Tehran hospitals. Iranian journal of Basic Medical Sciences 17(1), 21.

Momtaz H, Seifati SM, Tavakol M. 2015. Determining the prevalence and detection of the most prevalent virulence genes in Acinetobacter baumannii isolated from hospital infections. International Journal of Medical Laboratory 2(2), 87-97.

Moniri R, Farahani RK, Shajari G, Shirazi MN, Ghasemi A. 2010. Molecular epidemiology of aminoglycosides resistance in acinetobacter spp. With emergence of multidrug-resistant strains. Iranian Journal of Public Health 39(2), 63.

Shamim S, Abbas M, Qazi MH. 2015. Prevalence of Multidrug Resistant Acinetobacter baumannii in Hospitalized Patients in Lahore, Pakistan.  Pakistan Journal of Molecular Medicine 2(1), 23-28.

Sievert DM, Ricks P, Edwards JR, Schneider AMPH, Patel J, Srinivasan A, Kallen A, Limbago B, Fridkin S. 2013. National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infection Control & Hospital Epidemiology 34(1), 1-14.

Vaneechoutte M, Dijkshoorn L, Tjernberg I, Elaichouni A, de Vos PA, Claeys G, Verschraegen G. 1995. Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. Journal of Clinical Microbiology 33(1), 11-15.